1. tmk499596
2. wjmcgrath
3. 7942usculbe
4. techwood
1.techwood 01/22/2018
Holding for longterm tho
2.tmk499596 01/22/2018
Well... we are moving here
3.wjmcgrath 04/26/2018
uniQure Delivers Oral Presentation on Broad Set of Preclinical Data on AMT-130 in Huntington's Disease at the 2018 American Academy of Neurology Annual Meeting
4.wjmcgrath 12/03/2018
uniQure Announces Long-Term Clinical Data from Ongoing Phase I/II Trial of AMT-060 and Confirms Dose for AMT-061 Pivotal Study in Hemophilia B
5.tmk499596 01/08/2018
News...hmmm, stock droppin...
6.7942usculbe 03/14/2018
uniQure Announces 2017 Financial Results and Recent Company Progress
7.tmk499596 01/22/2018
Company has received an Orphan Medicinal Product Designation (OMPD) from the European Medicines Agency for AMT-130 in Huntington’s disease.
8.wjmcgrath 05/21/2018
Presents data showing successful liver transduction
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW